Simple screening tests for detection of carbapenemases in clinical isolates of nonfermentative Gram-negative bacteria

Indian Journal of Medical Research

Volumn 129, Issue 6, 2009, Pages 707-712

  Noyal, M J C ^a   Menezes, G A ^a   Harish, B N ^a   Sujatha, S ^a   Parija, S C ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

AmpC ; AmpC disk test; EDTA disk synergy test; Lactamases; Metallo lactamases; Modified Hodge test; Nonfermentative bacteria

Indexed keywords

BETA LACTAMASE AMPC; CEFOXITIN; CEFTAZIDIME; EDETIC ACID; MEROPENEM; METALLO BETA LACTAMASE;

ACINETOBACTER BAUMANNII; ACINETOBACTER LWOFFII; AMPC DISK TEST; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DISK DIFFUSION; DISK SYNERGY TEST; ENZYME ASSAY; ENZYME SYNTHESIS; INTERMETHOD COMPARISON; MODIFIED HODGE TEST; NONHUMAN; PSEUDOMONAS; SCREENING TEST;

ACINETOBACTER; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; PSEUDOMONAS;

EID: 70349558923     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Walsh TR, Bolmstrom A, Qwarnstrom A, Gales A. Evaluation of a new Etest for detecting metallo-β-lactamases in routine clinical testing. J Clin Microbiol 2002; 40: 2755-9.
2. Walsh TR, Toleman MA, Poirel L, Nordmann P. Metallo-β- lactamases: the quiet before the storm? Clin Microbiol Rev 2005; 18: 306-25.
3. Lee K, Chong Y, Shin HB, Kim YA, Yong D, Yum JH. Modifi ed Hodge and EDTA - disk synergy tests to screen metallo-β-lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin Microbiol Infect 2001; 7: 88-91.
4. Marchiaro P, Mussi MA, Ballerini V, Pasteran F, Viale AM, Vila AJ, et al. Sensitive EDTA-based microbiological assays for detection of metallo-β-lactamases in nonfermentative gram-negative bacteria. J Clin Microbiol 2005; 43: 5648-52.
5. Singhal S, Mathur T, Khan S, Upadhyay DJ, Chugh S, Gaind R, et al. Evaluation of methods for AmpC β-lactamase in gram negative clinical isolates from tertiary care hospitals. Indian J Med Microbiol 2005; 23: 120-4.
6. Coudron PE, Moland ES, Thomson KS. Occurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol 2000; 38: 1791-6.
7. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing, 19th information supplement (M100-S19). Wayne, PA: Clinical and Laboratory Standards Institute; 2009.
8. Senda K, Arakawa Y, Ichiyama S, Nakashima K, Ito H, Ohsuka S, et al. PCR detection of metallo-β-lactamase gene (blaIMP) in gram-negative rods resistant to broad-spectrum β-lactams. J Clin Microbiol 1996; 34: 2909-13.
9. Schreckenberger PC, Daneshvar MI, Weyant RS, Hollis DG. Acinetobacter, Achromobacter, Chryseobacterium, Moraxella, and other nonfermentative Gram-negative rods. In: Murray PR, Baron EJ, Jorgensen JH, Pfaller MA, Yolken RH, editors. Manual of clinical microbiology. 8th ed. Washington DC: ASM Press; 2003. p. 752-3.
10. Govan JRW. Pseudomonas, Stenotrophomonas, Burkholderia. In: Collee JG, Fraser AC, Marmion BP, Simmons A, editors. Mackie & McCartney practical medical microbiology. 14th ed. New York, London. Churchill Livingstone; 1996. p. 413-24.
11. Clinical Laboratory Standards Institute. Performance standards for antimicrobial disk susceptibility tests, Approved standard, 9th ed. CLSI document M2-A9. CLSI, Wayne, PA; 2006.
12. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobials disc susceptibility tests. Approved Standard, 7th ed. NCCLS document M2-A7. Wayne, PA: National Committee for Clinical Laboratory Standards; 2000.
13. Yong D, Lee K, Yum JH, Shin HB, Rossolini GM, Chong Y. Imipenem-EDTA disk method for differentiation of metallo- β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J Clin Microbiol 2002; 40: 3798-801.
14. Payne DJ, Bateson JH, Gasson BC, Proctor D, Khushi T, Farmer TH, et al. Inhibition of metallo-β-lactamases by a series of mercaptoacetic acid thiol ester derivatives. Antimicrob Agents Chemother 1997; 41: 135-40.
15. Walsh TR. The emergence and implications of metallo-β- lactamases in Gram-negative bacteria. Clin Microbiol Infect 2005; 11 (Suppl 6): S2-9.
16. Watanabe S, Iyobe S, Inoue M, Mitsuhashi S. Transferable imipenem resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1991; 35: 147-51.
17. Cornaglia G, Riccio ML, Mazzariol A, Lauretti L, Fontana R, Rossolini GM. Appearance of IMP-1 metallo-β-lactamase in Europe. Lancet 1999; 353: 899-900.
18. Koh TH, Babini GS, Woodford N, Sng LH, Hall LM, Livermore DM. Carbapenem-hydrolysing IMP-1 β-lactamase in Klebsiella pneumoniae in Singapore. Lancet 1999; 353: 2162-3.
19. Woodford N, Palepou MF, Babini GS, Bates J, Livermore DM. Carbapenemase-producing Pseudomonas aeruginosa in UK. Lancet 1998; 352: 546-7.
20. Navaneeth BV, Sridaran D, Sahay D, Belwadi MRS. A preliminary study on metallo-β-lactamase producing Pseudomonas aeruginosa in hospitalized patients. Indian J Med Res 2002; 116: 264-7.
21. Sinha M, Srinivasa H. Mechanisms of resistance to carbapenems in meropenem resistant Acinetobacter isolates from clinical samples. Indian J Med Microbiol 2007; 25: 21-5.
22. Quale J, Bratu S, Landman D, Heddurshetti R. Molecular epidemiology and mechanisms of carbapenem resistance in Acinetobacter baumannii endemic in New York city. Clin Infect Dis 2003; 37: 214-20.
23. Peleg AY, Franklin C, Bell JM, Spelman DW. Emergence of carbapenem resistance in Acinetobacter baumannii recovered from blood cultures in Australia. Infect Control Hosp Epidemiol 2006; 27: 759-61.
24. Andrade SS, Jones RN, Gales AC, Sader HS. Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001). J Antimicrob Chemother 2003; 52: 140-1.
25. Kanungo R, Srinivasan S, Devi S. Emerging resistance to carbapenems in hospital acquired Pseudomonas infection: a cause for concern. Indian J Pharmacol 2006; 38: 287-8.
26. Lee K, Lee WG, Uh Y, Ha GY, Cho J, Chong Y, Korean Nationwide Surveillance of Antimicrobial Resistance Group. VIM- and IMP-type metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. in Korean hospitals. Emerg Infect Dis 2003; 9: 868-71.
27. Jesudason MV, Kandathil AJ, Balaji V. Comparison of two methods to detect carbapenemase & metallo-β-lactamase production in clinical isolates. Indian J Med Res 2005; 121: 780-3.
28. Arakawa Y, Shibata N, Shibayama K, Kurokawa H, Yagi T, Fujiwara H, et al. Convenient test for screening metallo-β- lactamase-producing Gram-negative bacteria by using thiol compounds. J Clin Microbiol 2000; 38: 40-3.
29. Queenan AM, Bush K. Carbapenemases: the versatile betalactamases. Clin Microbiol Rev 2007; 20: 440-58.
30. Maragakis LL, Perl TM. Acinetobacter baumanni: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008; 46: 1254-63.
31. Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother 2007; 51: 3471-84.